Tanvex BioPharma (6541.TW) Q1 2026 Earnings

4MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.61
-1.33
-1.04
-0.76

Details

Expected EPS
-0.7609569122500001
Actual EPS
-1.61262392
Surprise EPS
-0.85
Surprise Percent
+111.92%

Description

Tanvex BioPharma (6541.TW) has reported earnings of -1.61262392 per share for Q1 2026.

0 Comments

Share your thoughts